Trials / Not Yet Recruiting
Not Yet RecruitingNCT06585579
The Effect of Mucogyne® Ovule on Wound Healing (ORIGYNE)
ORIGYNE (MUCO232) - the Effect of Mucogyne® Ovule on Wound Healing
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 144 (estimated)
- Sponsor
- Biocodex · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This clinical investigation is a post-market clinical follow-up performed to confirm the performance and safety of the Mucogyne® ovule medical device in promoting the process of wound healing, when used in accordance with its approved labelling, in the context of local cervicovaginal surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Mucogyne Ovule | In Mucogyne group, patient will receive 2 boxes of Mucogyne® ovule. 24 hours after intervention, the patient will apply Mucogyne® ovule, 1 ovule per day for 10 days, to be repeated as needed (for practices' homogenisation, after the 10th day, it is recommended to apply one ovule every second day, until EOS visit) |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2025-08-01
- Completion
- 2025-11-01
- First posted
- 2024-09-05
- Last updated
- 2024-09-05
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06585579. Inclusion in this directory is not an endorsement.